152 related articles for article (PubMed ID: 15088769)
21. [Influenza surveillance and control program of WHO].
Oshitani H
Nihon Rinsho; 2000 Nov; 58(11):2175-8. PubMed ID: 11225300
[TBL] [Abstract][Full Text] [Related]
22. The macro-epidemiology of influenza vaccination in 56 countries, 1997--2003.
Macroepidemiology of Influenza Vaccination (MIV) Study Group
Vaccine; 2005 Oct; 23(44):5133-43. PubMed ID: 16039762
[TBL] [Abstract][Full Text] [Related]
23. [Global influenza surveillance].
Taniguchi K
Nihon Rinsho; 2006 Oct; 64(10):1950-3. PubMed ID: 17037373
[TBL] [Abstract][Full Text] [Related]
24. Strategies for developing vaccines against H5N1 influenza A viruses.
Horimoto T; Kawaoka Y
Trends Mol Med; 2006 Nov; 12(11):506-14. PubMed ID: 17011235
[TBL] [Abstract][Full Text] [Related]
25. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.
Skowronski DM; De Serres G; Dickinson J; Petric M; Mak A; Fonseca K; Kwindt TL; Chan T; Bastien N; Charest H; Li Y
J Infect Dis; 2009 Jan; 199(2):168-79. PubMed ID: 19086914
[TBL] [Abstract][Full Text] [Related]
26. M2e-based universal influenza A vaccine.
Fiers W; De Filette M; El Bakkouri K; Schepens B; Roose K; Schotsaert M; Birkett A; Saelens X
Vaccine; 2009 Oct; 27(45):6280-3. PubMed ID: 19840661
[TBL] [Abstract][Full Text] [Related]
27. From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenza.
Wood JM; Robertson JS
Nat Rev Microbiol; 2004 Oct; 2(10):842-7. PubMed ID: 15378048
[TBL] [Abstract][Full Text] [Related]
28. The use of inactivated influenza vaccine in children.
Wright PF
Semin Pediatr Infect Dis; 2006 Oct; 17(4):200-5. PubMed ID: 17055371
[TBL] [Abstract][Full Text] [Related]
29. Establishment of pandemic influenza vaccine production capacity at Bio Farma, Indonesia.
Suhardono M; Ugiyadi D; Nurnaeni I; Emelia I
Vaccine; 2011 Jul; 29 Suppl 1():A22-5. PubMed ID: 21684423
[TBL] [Abstract][Full Text] [Related]
30. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
[TBL] [Abstract][Full Text] [Related]
31. [The 2006/'07 influenza season in the Netherlands and the vaccine composition for the 2007/'08 season].
de Jong JC; Rimmelzwaan GF; Donker GA; Meijer A; Fouchier RA; Osterhaus AD
Ned Tijdschr Geneeskd; 2007 Sep; 151(39):2158-65. PubMed ID: 17957994
[TBL] [Abstract][Full Text] [Related]
32. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
[TBL] [Abstract][Full Text] [Related]
33. Recombinant vaccines for influenza virus.
Tripp RA; Tompkins SM
Curr Opin Investig Drugs; 2008 Aug; 9(8):836-45. PubMed ID: 18666031
[TBL] [Abstract][Full Text] [Related]
34. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
[TBL] [Abstract][Full Text] [Related]
35. NEW technologies for meeting the global demand for pandemic influenza vaccines.
Fedson DS
Biologicals; 2008 Nov; 36(6):346-9. PubMed ID: 18715803
[TBL] [Abstract][Full Text] [Related]
36. Prevention of influenza: recommendations for influenza immunization of children, 2007-2008.
American Academy of Pediatrics Committee on Infectious Diseases
Pediatrics; 2008 Apr; 121(4):e1016-31. PubMed ID: 18381500
[TBL] [Abstract][Full Text] [Related]
37. Modeling pandemic preparedness scenarios: health economic implications of enhanced pandemic vaccine supply.
Medema JK; Zoellner YF; Ryan J; Palache AM
Virus Res; 2004 Jul; 103(1-2):9-15. PubMed ID: 15163482
[TBL] [Abstract][Full Text] [Related]
38. Progress with human H5N1 vaccines: a perspective from industry.
Palache B; Krause R
Expert Rev Vaccines; 2009 Apr; 8(4):391-400. PubMed ID: 19348556
[TBL] [Abstract][Full Text] [Related]
39. Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine--Marshfield, Wisconsin, 2007-08 influenza season.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Apr; 57(15):393-8. PubMed ID: 18418344
[TBL] [Abstract][Full Text] [Related]
40. Intent to receive influenza A (H1N1) 2009 monovalent and seasonal influenza vaccines - two counties, North Carolina, August 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(50):1401-5. PubMed ID: 20032923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
